What You Should Know:
– Ascensia Diabetes Care has announced the U.S. launch of the Eversense® 365 continuous glucose monitoring (CGM) system, an advancement in diabetes management.
– Developed by Senseonics Holdings, Inc., Eversense 365 is the world’s first and only CGM system to offer an entire year of continuous glucose monitoring with a single sensor. This innovative technology received FDA clearance last month for individuals with type 1 and type 2 diabetes aged 18 years and older.
Addressing the Challenges of Traditional CGMs
Eversense 365 tackles common frustrations associated with traditional CGMs, which typically require replacement every 10-14 days. Ascensia’s new commercial launch campaign highlights these challenges and how Eversense provides solutions:
- Longevity: Unlike shorter-term CGMs that often fail prematurely, Eversense 365 lasts for a full year, minimizing disruptions and providing long-term peace of mind.
- Durability: The system features a removable smart transmitter that can be easily reattached if accidentally knocked off, preventing device waste.
- Accuracy: Eversense 365 offers exceptional accuracy with minimal false alerts, even during sleep, enabling confident diabetes management decisions.
- Comfort: The sensor is implanted under the skin, and the gentle, silicone-based adhesives for the transmitter are changed daily, minimizing skin irritation and discomfort.
Improved Diabetes Management and Quality of Life
Studies have shown that Eversense can reduce diabetes distress and significantly improve glucose control. By minimizing the burden of CGM management, Eversense 365 empowers individuals to take control of their diabetes and enhance their quality of life.
Access and Affordability
Eversense 365 is widely covered by commercial insurance in the U.S., and Ascensia is actively working to expand access. The company is introducing the Eversense 365 Payment Assistance and Simple Savings (PASS) program to further enhance affordability. This program allows eligible individuals to pay as little as $199 out-of-pocket for a full year of continuous glucose monitoring with a single annual payment.
Availability
To learn more about Eversense 365, potential users can visit www.eversensecgm.com. Healthcare professionals interested in offering the system can sign up at www.ascensiadiabetes.com/eversense/become-a-provider/ or contact 844-SENSE4U (736-7348).
